MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Caicedo, Andrés ^a,b   Fritz, Vanessa ^c   Brondello, Jean Marc ^a,b   Ayala, Mickaël ^a,b   Dennemont, Indira ^a,b   Abdellaoui, Naoill ^a,b   De Fraipont, Florence ^d,e,f   Moisan, Anaïck ^d,e,f   Prouteau, Claire Angebault ^a,g   Boukhaddaoui, Hassan ^a,g   Jorgensen, Christian ^a,b,h   Vignais, Marie Luce ^a,b  

^a HÔPITAL SAINT ELOI   (France)

^b INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^c CNRS   (France)

^d UNIV GRENOBLE ALPES   (France)

^e GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

^g Montpellier University Medical Center   (France)

^h LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE;

BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; COCULTURE; FLOW CYTOMETRY; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; METABOLOMICS; MITOCHONDRION; NEOPLASM; PROCEDURES; REPRODUCIBILITY; TIME LAPSE IMAGING; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COCULTURE TECHNIQUES; FLOW CYTOMETRY; HUMANS; MESENCHYMAL STROMAL CELLS; METABOLOMICS; MITOCHONDRIA; NEOPLASMS; REPRODUCIBILITY OF RESULTS; TIME-LAPSE IMAGING;

EID: 84924859493     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09073     Document Type: Article

References (62)

1. Vafai, S. B. & Mootha, V. K. Mitochondrial disorders as windows into an ancient organelle. Nature 491, 374-83 (2012).
2. Nunnari, J. & Suomalainen, A. Mitochondria: in sickness and in health. Cell 148, 1145-59 (2012).
3. Chinnery, P. F. Mitochondrial Disorders Overview. In: Pagon, R.A., Adam, M.P. & Ardinger, H.H. et al . editors. GeneReviewsH [Internet]. Seattle (WA): University of Washington, Seattle; 1993- 2014. Available from: http://www.ncbi. nlm.nih.gov/books/NBK1224/ (2014) 14/08/2014.
4. Chandel, N. S. Mitochondria as signaling organelles. BMC Biol 12, 34 (2014).
5. Schulze, A. & Harris, A. L. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491, 364-73 (2012).
6. Martinez-Outschoorn, U. E. et al. Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells. Cancer Biol Ther 12, 924-38 (2011).
7. Barbosa, I. A., Machado, N. G., Skildum, A. J., Scott, P. M. & Oliveira, P. J. Mitochondrial remodeling in cancer metabolism and survival: potential for new therapies. Biochim Biophys Acta 1826, 238-54 (2012).
8. LeBleu, V. S. et al. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol 16, 992-1003 (2014).
9. Tatsuta, T., Scharwey, M. &Langer, T. Mitochondrial lipid trafficking. Trends Cell Biol 24, 44-52 (2014).
10. Islam, M. N. et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. NatMed 18, 759-65 (2012).
11. Pasquier, J. et al. Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance. J Transl Med 11, 94 (2013).
12. Plotnikov, E. Y., Khryapenkova, T. G., Galkina, S. I., Sukhikh, G. T. & Zorov, D. B. Cytoplasm and organelle transfer between mesenchymal multipotent stromal cells and renal tubular cells in co-culture. Exp Cell Res 316, 2447-55 (2010).
13. Spees, J. L., Olson, S. D., Whitney, M. J. & Prockop, D. J. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci U S A 103, 1283-8 (2006).
14. Liu, K. et al.Mesenchymal stem cells rescue injured endothelial cells in an in vitro ischemia-reperfusion model via tunneling nanotube like structure-mediated mitochondrial transfer. Microvasc Res 92, 10-8 (2014).
15. Bukoreshtliev, N. V. et al. Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells. FEBS Lett 583, 1481-8 (2009).
16. Gurke, S. et al. Tunneling nanotube (TNT)-like structures facilitate a constitutive, actomyosin-dependent exchange of endocytic organelles between normal rat kidney cells. Exp Cell Res 314, 3669-83 (2008).
17. Vallabhaneni, K. C., Haller, H. & Dumler, I. Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondrial transfer via tunneling nanotubes. Stem Cells Dev 21, 3104-13 (2012).
18. Ahmad, T. et al.Miro1 regulates intercellular mitochondrial transport&enhances mesenchymal stem cell rescue efficacy. Embo J 33, 994-1010 (2014).
19. Plotnikov, E. Y. et al. Cell-to-cell cross-talk between mesenchymal stem cells and cardiomyocytes in co-culture. J Cell Mol Med 12, 1622-31 (2008).
20. Acquistapace, A. et al. Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells 29, 812-24 (2011).
21. Abounit, S. & Zurzolo, C. Wiring through tunneling nanotubes - from electrical signals to organelle transfer. J Cell Sci 125, 1089-98 (2012).
22. Keating, A. Mesenchymal stromal cells: new directions. Cell Stem Cell 10, 709-16 (2012).
23. de Girolamo, L. et al. Mesenchymal stem/stromal cells: a new "cells as drugs" paradigm. Efficacy and critical aspects in cell therapy. Curr Pharm Des 19, 2459-73 (2013).
24. Jing, Y. et al. Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelialmesenchymal transition. PLoS One 7, e43272 (2012).
25. Jung, Y. et al. Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nat Commun 4, 1795 (2013).
26. Ohkouchi, S. et al . Mesenchymal Stromal Cells Protect Cancer Cells From ROSinduced Apoptosis and Enhance the Warburg Effect by Secreting STC1. Mol Ther 20, 417-23 (2012).
27. Karnoub, A. E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-63 (2007).
28. Rattigan, Y., Hsu, J. M., Mishra, P. J., Glod, J. & Banerjee, D. Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. Exp Cell Res 316, 3417-24 (2010).
29. Goldstein, R. H., Reagan, M. R., Anderson, K., Kaplan, D. L. & Rosenblatt, M. Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. Cancer Res 70, 10044-50 (2010).
30. Huang, W. H. et al. Mesenchymal stem cells promote growth and angiogenesis of tumors in mice. Oncogene 32, 4343-54 (2013).
31. Houthuijzen, J. M., Daenen, L. G., Roodhart, J. M. & Voest, E. E. The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression. Br J Cancer 106, 1901-06 (2012).
32. Nowicka, A. et al. Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance. PLoS One 8, e81859 (2013).
33. Serakinci, N., Fahrioglu, U. & Christensen, R. Mesenchymal stem cells, cancer challenges and new directions. Eur J Cancer 50, 1522-30 (2014).
34. Luo, J. et al. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling. Oncogene 33, 2768-78 (2014).
35. Barcellos-de-Souza, P., Gori, V., Bambi, F. & Chiarugi, P. Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. Biochim Biophys Acta 1836, 321-35 (2013).
36. Keramidas, M. et al. The dual effect of mscs on tumour growth and tumour angiogenesis. Stem Cell Res Ther 4, 41 (2013).
37. Gordon, J. A., Lisle, J. W., Alman, B. A. & Lian, J. B. Disruption of crosstalk between mesenchymal stromal and tumor cells in bone marrow as a therapeutic target to prevent metastatic bone disease. J Cell Physiol 229, 1884-6 (2014).
38. Torsvik, A. & Bjerkvig, R. Mesenchymal stem cell signaling in cancer progression. Cancer Treat Rev 39, 180-8 (2013).
39. Zhang, W. et al. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat Cell Biol 14, 276-86 (2012).
40. Bonuccelli, G. et al. Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 9, 3506-14 (2010).
41. Takeda, K. et al. Influence of intergeneric/interspecies mitochondrial injection; parthenogenetic development of bovine oocytes after injection of mitochondria derived from somatic cells. J Reprod Dev 58, 323-9 (2012).
42. Takeda, K. et al. Microinjection of cytoplasm or mitochondria derived from somatic cells affects parthenogenetic development of murine oocytes. Biol Reprod 72, 1397-404 (2005).
43. Van Blerkom, J., Sinclair, J. & Davis, P. Mitochondrial transfer between oocytes: potential applications of mitochondrial donation and the issue of heteroplasmy. Hum Reprod 13, 2857-68 (1998).
44. Ishikawa, K. et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320, 661-4 (2008).
45. Kaipparettu, B. A., Ma, Y. &Wong, L. J. Functional effects of cancer mitochondria on energy metabolism and tumorigenesis: utility of transmitochondrial cybrids. Ann N Y Acad Sci 1201, 137-46 (2010).
46. McAllister, S. S. &Weinberg, R. A. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol 16, 717-27 (2014).
47. Gustafsson, M. G. et al. Three-dimensional resolution doubling in wide-field fluorescence microscopy by structured illumination. Biophys J 94, 4957-70 (2008).
48. Wang, W. et al. Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab 15, 186-200 (2012).
49. Youle, R. J.&Narendra, D. P. Mechanisms ofmitophagy. Nat RevMol Cell Biol 12, 9-14 (2011).
50. Pellegrino, M. W., Nargund, A. M. & Haynes, C. M. Signaling the mitochondrial unfolded protein response. Biochim Biophys Acta 1833, 410-6 (2013).
51. Krysko, D. V. et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 32, 157-64 (2011).
52. Tait, S. W. & Green, D. R.Mitochondria and cell signalling. J Cell Sci 125, 807-15 (2012).
53. Sun, S. et al. Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways. PLoS One 8, e59989 (2013).
54. Ye, K., Lu, J., Ma, F., Keinan, A.& Gu, Z. Extensive pathogenicity of mitochondrial heteroplasmy in healthy human individuals. Proc Natl Acad Sci U S A 111, 10654-9 (2014).
55. Mishra, P. & Chan, D. C. Mitochondrial dynamics and inheritance during cell division, development and disease. Nat Rev Mol Cell Biol 15, 634-46 (2014).
56. Masuzawa, A. et al. Transplantation of autologously derived mitochondria protects the heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 304, H966-82 (2013).
57. Kitani, T. et al.Direct human mitochondrial transfer: a novel concept based on the endosymbiotic theory. Transplant Proc 46, 1233-6 (2014).
58. Warburg, O. On the origin of cancer cells. Science 123, 309-14 (1956).
59. Roodhart, J. M. et al. Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell 20, 370-83 (2011).
60. Folmes, C. D., Dzeja, P. P., Nelson, T. J. & Terzic, A. Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell 11, 596-606 (2012).
61. Blanco, F. J., Rego, I. & Ruiz-Romero, C. The role of mitochondria in osteoarthritis. Nat Rev Rheumatol 7, 161-9 (2011).
62. Lyons, E. A., Scheible, M. K., Sturk-Andreaggi, K., Irwin, J. A. & Just, R. S. A highthroughput Sanger strategy for human mitochondrial genome sequencing. BMC Genomics 14, 881 (2013).